65 related articles for article (PubMed ID: 2343109)
1. Cardiovascular MR imaging with iron oxide particles: utility of a superparamagnetic contrast agent and the role of diffusion in signal loss.
Rozenman Y; Zou XM; Kantor HL
Radiology; 1990 Jun; 175(3):655-9. PubMed ID: 2343109
[TBL] [Abstract][Full Text] [Related]
2. Signal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images: the role of diffusion.
Rozneman Y; Zou XM; Kantor HL
Magn Reson Med; 1990 Apr; 14(1):31-9. PubMed ID: 2352471
[TBL] [Abstract][Full Text] [Related]
3. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits.
Hamm B; Taupitz M; Hussmann P; Wagner S; Wolf KJ
AJR Am J Roentgenol; 1992 Jan; 158(1):183-90. PubMed ID: 1727343
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
Weissleder R; Hahn PF; Stark DD; Elizondo G; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Nov; 169(2):399-403. PubMed ID: 3174987
[TBL] [Abstract][Full Text] [Related]
5. Experimental lymph node metastases: enhanced detection with MR lymphography.
Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide-enhanced MR imaging: pulse sequence optimization for detection of liver cancer.
Fretz CJ; Elizondo G; Weissleder R; Hahn PF; Stark DD; Ferrucci JT
Radiology; 1989 Aug; 172(2):393-7. PubMed ID: 2748820
[TBL] [Abstract][Full Text] [Related]
7. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
Hahn PF; Stark DD; Lewis JM; Saini S; Elizondo G; Weissleder R; Fretz CJ; Ferrucci JT
Radiology; 1990 Jun; 175(3):695-700. PubMed ID: 2343116
[TBL] [Abstract][Full Text] [Related]
8. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.
Saini S; Stark DD; Hahn PF; Bousquet JC; Introcasso J; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):217-22. PubMed ID: 3786766
[TBL] [Abstract][Full Text] [Related]
9. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.
Saini S; Stark DD; Hahn PF; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):211-6. PubMed ID: 3786765
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
Majumdar S; Zoghbi S; Pope CF; Gore JC
Radiology; 1988 Dec; 169(3):653-8. PubMed ID: 3186986
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model.
Kreft B; Block W; Dombrowski F; Fackeldey A; Bachmann R; Mühlhäuser J; Träber F; Oksendal A; Pfeifer U; Schild HH
AJR Am J Roentgenol; 1998 Mar; 170(3):661-8. PubMed ID: 9490949
[TBL] [Abstract][Full Text] [Related]
12. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats.
Weissleder R; Stark DD; Compton CC; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Dec; 149(6):1161-5. PubMed ID: 3318339
[TBL] [Abstract][Full Text] [Related]
13. Functional-morphologic MR imaging with ultrasmall superparamagnetic particles of iron oxide in acute and chronic soft-tissue infection: study in rats.
Kaim AH; Jundt G; Wischer T; O'Reilly T; Frohlich J; von Schulthess GK; Allegrini PR
Radiology; 2003 Apr; 227(1):169-74. PubMed ID: 12615996
[TBL] [Abstract][Full Text] [Related]
14. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Marchal G; Van Hecke P; Demaerel P; Decrop E; Kennis C; Baert AL; van der Schueren E
AJR Am J Roentgenol; 1989 Apr; 152(4):771-5. PubMed ID: 2784260
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging.
Kawamori Y; Matsui O; Kadoya M; Yoshikawa J; Demachi H; Takashima T
Radiology; 1992 Apr; 183(1):65-72. PubMed ID: 1549696
[TBL] [Abstract][Full Text] [Related]
16. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
Liu X; Xu YK; Huang QL; Wu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals.
Frank H; Weissleder R; Brady TJ
AJR Am J Roentgenol; 1994 Jan; 162(1):209-13. PubMed ID: 8273667
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation.
Rivière C; Boudghène FP; Gazeau F; Roger J; Pons JN; Laissy JP; Allaire E; Michel JB; Letourneur D; Deux JF
Radiology; 2005 Jun; 235(3):959-67. PubMed ID: 15845788
[TBL] [Abstract][Full Text] [Related]
19. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
20. Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI.
Lüdemann L; Schmitt B; Podrabsky P; Schnackenburg B; Böck J; Gutberlet M
Eur J Radiol; 2007 May; 62(2):247-56. PubMed ID: 17188443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
